Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

Newsroom

  • Portrait of Young Girl Patient in Exam Room

    Leader in Care

    Throughout the Washington, D.C, region, the nation and the world, Children’s National Hospital is recognized for our expertise and innovation in pediatric care and as an advocate for all children.

    Read more

Latest News

Children’s National Hospital welcomes Muller Fabbri, M.D., Ph.D., expert in microRNAs in cancer biology, as associate director of the Center for Cancer and Immunology Research

Children’s National Hospital is pleased to announce it has selected Muller Fabbri, M.D., Ph.D., as associate director for the Center for Cancer and Immunology Research at the Children’s National Research Institute. In this role, he will build and lead the Cancer Biology Program while developing and conducting basic and translational research. Dr. Fabbri will also develop multidisciplinary research projects with various clinical divisions, including oncology, blood and marrow transplantation, pathology and hematology.

Children’s National Hospital hosts First Lady and Dr. Fauci as they encourage families to get COVID vaccine

Twelve-year-old Skylah Jackson from Ward 8 in Washington, D.C., had a special guest in her support network while getting her COVID-19 vaccine today – the First Lady of the United States. First Lady Dr. Jill Biden and Dr. Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases, toured the COVID-19 vaccine clinic at Children’s National Hospital.

Prestigious annual pediatric medical device competition reveals five finalists

Five finalists have been named in the prestigious annual “Make Your Medical Device Pitch for Kids!” competition presented by the National Capital Consortium for Pediatric Device Innovation (NCC-PDI). Representing innovations in electrophysiology devices that treat congenital heart disease (CHD) and arrhythmias in pediatric patients, these five finalists now have access to a pediatric accelerator program led by MedTech Innovator and will compete for a share of $150,000 in grant funding from the U.S. Food and Drug Administration (FDA) in the final virtual pitch event in September 2021. The pediatric pitch event is part of the 9th Annual Symposium on Pediatric Device Innovation, co-located with the MedTech Conference, powered by AdvaMed.
Antibodies responding to covid-19 coronavirus, illustration

Immunocompromised pediatric patients showed T-cell activity and humoral immunity against SARS-CoV-2

According to data from a cohort of adult and pediatric patients with antibody deficiencies, patients that often fail to make protective immune responses to infections and vaccinations showed robust T-cell activity and humoral immunity against SARS-CoV-2 structural proteins. The new study, led by researchers at Children’s National Hospital, is the first to demonstrate a robust T-cell response against SARS-CoV-2 in immunocompromised patients.